Name | APTEKA N33, OAO |
|---|
INN | 7313007575 |
|---|
KPP | 731301001 |
|---|
OGRN | 1127313000253 |
|---|
OKPO | 25294942 |
|---|
Address | 433910, Ul'yanovskaya Oblast', r-n Radischevskiy, rp. Radischevo, ul. Kirova, d. D.17 |
|---|
Phone | 2-18-30 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75.1 | Additional activity | Retail sale of cosmetic and toilet articles in specialised stores |
Registration date | 18.05.2012 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N5 po Ul'yanovskoy oblasti |
|---|
|
APTEKA N33, OAO (Ulyanovsk Oblast; INN 7313007575) was registered on 18 May 2012. The company's authorized capital as of July 1, 2012 was 945000 rub. Principal activities of APTEKA N33, OAO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retail sale of cosmetic and toilet articles in specialised stores (47.75.1). |
Economic indicators2023
Net profit (RAS) of APTEKA N33, OAO dropped in 2023 18.67 times to 15.00 thousand RUB from 280.00 thousand RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 10.45% to 33.30 million RUB from 37.19 million RUB in 2022; cost of goods sold decreased by 10.62% to 25.98 million RUB from 29.07 million RUB; sales profit fell by 40.13% to 182.00 thousand RUB from 304.00 thousand RUB. 2022
Net profit (RAS) of APTEKA N33, OAO grew over 2022 1.94 times to 280.00 thousand RUB from 144.00 thousand RUB over 2021, the company informed. Revenue decreased in the accounting period by 1.19% to 37.19 million RUB from 37.64 million RUB in 2021; cost of goods sold decreased by 2.27% to 29.07 million RUB from 29.74 million RUB; sales profit fell by 41.65% to 304.00 thousand RUB from 521.00 thousand RUB. 2021
Net profit (RAS) of APTEKA N33, OAO grew over 2021 by 2.86% to 144.00 thousand RUB from 140.00 thousand RUB over 2020, the company informed. Revenue decreased in the accounting period by 3.08% to 37.64 million RUB from 38.84 million RUB in 2020; cost of goods sold decreased by 3.92% to 29.74 million RUB from 30.96 million RUB; sales profit fell by 11.69% to 521.00 thousand RUB from 590.00 thousand RUB. 2020
Net profit (RAS) of APTEKA N33, OAO dropped in 2020 by 23.50% to 140.00 thousand RUB from 183.00 thousand RUB over the same period in 2019, the company informed. Revenue increased in the accounting period by 20.11% to 38.84 million RUB from 32.33 million RUB over 2019; cost of goods sold grew by 20.45% to 30.96 million RUB from 25.70 million RUB; sales profit went up 1.93 times to 590.00 thousand RUB from 305.00 thousand RUB. 2019
Net profit (RAS) of APTEKA N33, OAO grew over 2019 11.44 times to 183.00 thousand RUB from 16.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 29.17% to 32.33 million RUB from 25.03 million RUB over 2018; cost of goods sold grew by 27.55% to 25.70 million RUB from 20.15 million RUB; sales profit went up 4.92 times to 305.00 thousand RUB from 62.00 thousand RUB. 2018
Net profit (RAS) of APTEKA N33, OAO dropped in 2018 9.12 times to 16.00 thousand RUB from 146.00 thousand RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 0.84% to 25.03 million RUB from 24.82 million RUB over 2017; cost of goods sold decreased by 0.63% to 20.15 million RUB from 20.28 million RUB; sales profit fell 4.08 times to 62.00 thousand RUB from 253.00 thousand RUB. 2017
Net profit (RAS) of APTEKA N33, OAO grew over 2017 36.50 times to 146.00 thousand RUB from 4.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period by 12.51% to 24.82 million RUB from 22.06 million RUB over 2016; cost of goods sold grew by 11.27% to 20.28 million RUB from 18.22 million RUB; sales profit went up 3.24 times to 253.00 thousand RUB from 78.00 thousand RUB. 2016
Net profit (RAS) of APTEKA N33, OAO dropped in 2016 13.50 times to 4.00 thousand RUB from 54.00 thousand RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 4.54% to 22.06 million RUB from 23.11 million RUB in 2015; cost of goods sold decreased by 3.49% to 18.22 million RUB from 18.88 million RUB; sales profit fell by 49.02% to 78.00 thousand RUB from 153.00 thousand RUB. 2014
Net profit (RAS) of Apteka N33, OAO dropped in 2014 2.02 times to 48.00 thousand RUB from 97.00 thousand RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 3.86% to 20.48 million RUB from 19.72 million RUB over 2013; cost of goods sold grew by 3.95% to 16.35 million RUB from 15.73 million RUB; sales profit fell by 43.84% to 114.00 thousand RUB from 203.00 thousand RUB. 2013
Net profit (RAS) of Apteka N33, OAO grew over 2013 by 4.30% to 97.00 thousand RUB from 93.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period 1.72 times to 19.72 million RUB from 11.50 million RUB over 2012; cost of goods sold grew 1.73 times to 15.73 million RUB from 9.10 million RUB; sales profit went up by 40.00% to 203.00 thousand RUB from 145.00 thousand RUB. 2012
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|